Clinical Trial Update: Study to Evaluate the Efficacy and Safety of AMG 714 in Adult Patients With Type II Refractory Celiac Disease [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating AMG 714 in adults with Type II Refractory Celiac Disease (RCD-II) and associated in-situ small bowel T-cell lymphoma; study completed w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Bowel T-cell Lymphoma
• Type Ii Refractory Celiac Disease

Drugs mentioned

• AMG 714

Snippet

Sponsor: Amgen | Conditions: Type II Refractory Celiac Disease (RCD-II), In-situ Small Bowel T-cell Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2019-12-27